Tricuspid valve disease and cardiac implantable electronic devices

Eur Heart J. 2024 Feb 1;45(5):346-365. doi: 10.1093/eurheartj/ehad783.

Abstract

The role of cardiac implantable electronic device (CIED)-related tricuspid regurgitation (TR) is increasingly recognized as an independent clinical entity. Hence, interventional TR treatment options continuously evolve, surgical risk assessment and peri-operative care improve the management of CIED-related TR, and the role of lead extraction is of high interest. Furthermore, novel surgical and interventional tricuspid valve treatment options are increasingly applied to patients suffering from TR associated with or related to CIEDs. This multidisciplinary review article developed with electrophysiologists, interventional cardiologists, imaging specialists, and cardiac surgeons aims to give an overview of the mechanisms of disease, diagnostics, and proposes treatment algorithms of patients suffering from TR associated with CIED lead(s) or leadless pacemakers.

Keywords: Cardiac implantable electronic device; Lead related; Pacemaker; Tricuspid regurgitation.

Publication types

  • Review

MeSH terms

  • Defibrillators, Implantable* / adverse effects
  • Humans
  • Pacemaker, Artificial* / adverse effects
  • Retrospective Studies
  • Rheumatic Heart Disease* / complications
  • Tricuspid Valve / diagnostic imaging
  • Tricuspid Valve / surgery
  • Tricuspid Valve Insufficiency* / complications
  • Tricuspid Valve Insufficiency* / surgery